康希诺跌2.50% 2020年上市募52亿中信证券保荐

Group 1 - The stock price of CanSino Biologics (688185.SH) fell by 2.50% to 65.63 yuan as of the market close [1] - CanSino was listed on the Shanghai Stock Exchange's STAR Market on August 13, 2020, with an initial issuance of 24.8 million shares at a price of 209.71 yuan per share, currently in a state of decline [1] - The total funds raised from the initial public offering (IPO) amounted to 5.201 billion yuan, with a net amount of 4.979 billion yuan after deducting issuance costs, exceeding the original plan by 3.979 billion yuan [1] Group 2 - The IPO issuance costs were 221 million yuan, with underwriting and sponsorship fees accounting for 205 million yuan [2] - CITIC Securities, as a participating underwriter, received 496,000 shares, representing 2.00% of the total shares issued, with an investment amount of 104 million yuan [2]